Two novel mutations within FREM1 gene in patients with bifid nose

BMC Pediatr. 2023 Dec 14;23(1):631. doi: 10.1186/s12887-023-04453-9.

Abstract

Background: Bifid nose is a rare congenital deformity and the etiology is unknown. The purpose of this study was to report genetic variation in family of patients with bifid nose.

Methods: Twenty-three consecutive patients who were diagnosed with mild bifid nose were operated with z-plasty from 2009 to 2021. Three underage patients (a pair of twins and a girl) from two family lines, who came to our hospital for surgical treatment, were enrolled. Whole exome sequencing and Sanger sequencing were conducted. Z-shaped flaps were created and the cartilago alaris major were re-stitched. Photographs and CT scan before and after surgery were obtained. Clinical outcomes, complications and patients' satisfaction were evaluated and analyzed. The follow-up time ranges from 2 to 3 years (2.4 ± 1.2 years).

Results: Most patients were satisfied with the outcome (96.2%). The nasal deformities were corrected successfully with z-plasty technique in one-stage. FREM1 c.870_876del and c.2 T > C were detected with Whole exome sequencing, which have not been reported before. The results of Sanger sequencing were consistent with those of Whole exome sequencing.

Conclusions: The newly detected mutations of FREM1 have a certain heritability, and are helpful to make an accurate diagnosis and provide a better understanding of bifid nose mechanism. Z-plasty technique can be an effective technical approach for correcting mild bifid nose deformity.

Keywords: Bifid nose; FREM1 gene mutation; Frontonasal dysplasia; Tessier No.0.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Mutation
  • Nose Diseases* / diagnosis
  • Nose Diseases* / surgery
  • Nose* / abnormalities
  • Nose* / surgery
  • Tomography, X-Ray Computed

Substances

  • Frem1 protein, human

Supplementary concepts

  • Bifid nose